I thank the committee for the opportunity to discuss the important public health topic of drug and alcohol use and the issues facing local drug and alcohol task forces. I am accompanied, from the Department of Health, by Ms Siobhán McArdle, assistant secretary, and Mr. Jim Walsh, principal officer. I am also joined by a colleague from the HSE national social inclusion office, Mr. Joe Doyle.
Drug use is a serious health issue with long-term implications not just for the person who uses illicit drugs, but for their family and the community around them. I am strongly committed to a health-led response which treats drug addiction first and foremost as a public health issue and which also diverts people from the criminal justice system towards effective programmes that support rehabilitation and recovery.
The Government’s policy on drug use is set out in the national drugs strategy, Reducing Harm, Supporting Recovery 2017-2025. The central tenet of the strategy is that drug use should be dealt with as a public health issue. It advocates for a compassionate response to individuals who use drugs. The programme for Government reiterates the health-led approach to drug use and the shift to this approach to drug use continues to evolve. Drug use is a dynamic situation to which policy must adapt in a flexible manner.
Our strategic priorities include prevention of drug use among children and young people; access to, and delivery of, drug services in the community and harm reduction responses and integrated care pathways for high-risk drug users; the social determinants and consequences of drugs use; alternatives to coercive sanctions for drug offences; and evidence-informed and outcomes-focused policy and implementation.
In 2024, the Department of Health provided funding of more that €160 million for the provision of drug services. Approximately €65 million or 40% of this funding is allocated by the HSE to community-based organisations. Drug and alcohol task forces play an important role in supporting the implementation of the national drugs strategy in communities by co-ordinating the response to drugs at local and regional level. There are ten regional and 14 local drug and alcohol task forces in operation across Ireland. They are responsible for supporting the implementation of the national strategy, Reducing Harm, Supporting Recovery 2017-2025, in the context of local population needs.
It is important to acknowledge the contribution of the independent chairpersons and the members of the task forces to addressing drug issues. The independent chairpersons play a key role in bringing together the various stakeholders to work together in a collaborative manner. The work of the task forces is supported by the HSE, which employs a co-ordinator for each task force and provides the channel of funding for the services overseen by the task force. In total, the Department of Health provides more than €28 million in recurring funding for drug services and related initiatives overseen by the task forces. Of this, €18 million goes to the 14 local task forces, with annual funding ranging from €1 million to €2 million. The €18 million represents 11% of the funding allocated by the Department of Health every year for drug services, and 28% of that allocated for community-based services.
Since 2020, the Department has allocated a total of €13.1 million in additional recurring funding to support existing community-based services and develop new services. This additional funding has been allocated on the basis of population across the nine community healthcare organisations which have recently been amalgamated as six health regions. While not ring-fenced by individual task forces, the additional funding has benefited drug services across all task force areas.
The drug and alcohol task forces contribute to the priorities in the national drugs strategy and are represented on the oversight structures for the strategy, including the strategic implementation groups. These groups are responsible for implementing a range of actions in the strategic action plan for 2023 and 2024. One strategic priority to which the task forces contribute in a major way is to enhance access to, and delivery of, drug services in the community. Drug treatment demand has greatly increased since 2017. In this period, the number of new cases treated for problematic drug use has grown from 8,922 to 13,104, an increase in new cases of 4,000, or 47%. From 2022 to 2023, the number of cases increased by more than 1,000. The local task force areas account for just under half of the total number of new cases in 2023. The remaining 53% fall within the geographical remit of the regional task forces.
There is geographical variation in the number of people accessing treatment for the first time, with some areas recording a higher demand for services than others. This increase in treatment cases reflects growing demand, as well as the additional investment under the national drugs strategy over the past few years in expanding access to, and availability of, treatment, for those who are seeking help with addiction issues. As Minister of State with responsibility in this area, I have prioritised investment in drug services to ensure these are available to all those who need them and in all locations where they are needed. This is in line with the Sláintecare objective of ensuring equity of access to healthcare services.
To better inform the planning and funding of drug services across the new health regions, the Department of Health is undertaking an audit of drug services. The first output of the audit is an interactive map of 442 publicly funded services across the country. This map suggests an uneven distribution of services, as well as a fragmentation of services across the country. The next step is to audit current service provision, based on treatment demand and population need, to inform the planning of drug services in the new HSE health regions.
Another strategic priority which the task forces support is addressing the social determinants and consequences of drug uses in disadvantaged communities. I recognise the additional challenges arising from drug use in communities where there are high levels of poverty and deprivation. Poverty and deprivation are government-wide issues which affect employment, education, housing, health, policing and community safety.
The Department of Health and the local task force chairpersons network jointly convened a conference in May 2023 to examine local responses to problematic drug use. The conference highlighted the importance of a joined-up approach involving Government Departments and local stakeholders, including the drug and alcohol task forces and the Sláintecare healthy communities programme. One aspect of drug use that has a corrosive impact on families and local communities is drug-related intimidation and violence, DRIVE. A recent initiative developed by the task forces and supported by the Department of Health is the DRIVE project to address this violence.
DRIVE is an interagency project set up to develop systems and structures across the country, facilitated by the local and regional drug and alcohol task forces, to support people who experience drug-related violence.
The Department of Health is the lead sponsor and funder of the DRIVE project and provides annual funding of €250,000 to support the work of the project. The Department of Justice, An Garda Síochána and the Probation Service are also key partners in the project. An Garda Síochána has appointed 30 inspectors who are totally focused on this issue.
I recently met the chair and co-ordinator of the DRIVE project to discuss plans for a national awareness campaign on drug-related intimidation. This campaign aims to address issues of stigma and fear, to deliver a message of hope and to advise people of how to access help. I acknowledge the positive, collaborative working relationship between the Department of Health and the chairs of the drug and alcohol task forces. In August, I met the chairpersons network to outline to them the additional funding being provided to sustain community-based drug services, covering both operational and staffing costs and I understand a further meeting has been arranged for 11 November. Funding of €2.3 million was allocated to sustain community-based drug services and support people in recovery. In addition, Department officials meet the chairpersons network on an ongoing basis to address operational and governance issues and to provide updates on new funding opportunities.
I will turn now to the report of the Citizens' Assembly on Drugs Use and the plans for drawing up a new national drugs strategy, which I know are of major interest to the task forces. I acknowledge that the implementation of the recommendations of the citizens' assembly will require a major step-change to develop a comprehensive health-led approach to drugs use. The deliberations of the Joint Committee on Drugs Use, which recently published an interim report, are also relevant to strengthening this approach. The vehicle to implement the recommendations of the citizens' assembly is the new national drugs strategy. It is proposed to prepare a draft of the next national drugs strategy in early 2025 informed by an evaluation of the current strategy, the Government response to the recommendations of the citizens' assembly and the Joint Committee on Drugs Use and the 800 submissions made to the citizens' assembly.
Task forces will play an important role in the design and implementation of the new national drugs strategy. I look forward to continuing the positive working relationship between myself as Minister, officials in the Department of Health and the chairpersons network and to having regular engagements on issues of common concern. As Minister with responsibility for the national drugs strategy, I am fully committed to ensuring we move forward with a health-led approach that reduces the harms of drug use, supports recovery and provides measurable benefits to the lives of everyone affected by the use of drugs.